ADC target proteins are the core target molecules in the research and development of antibody-drug conjugates (ADCs). These are primarily membrane protein antigens that are highly expressed on the surface of tumor cells and exhibit strong internalization capacity, including molecules such as Claudin 18.2, HER2, TROP2, Nectin-4, CD79B, and EGFR. Through specific recognition by antibodies, they mediate the internalization and delivery of cytotoxic payloads, enabling the precise elimination of tumor cells. These products are suitable for ADC target validation, antibody screening, affinity testing, and conjugation process optimization, and serve as essential tool proteins in the development of precision oncology therapies.

No Data Available
0